INTECH Investment Management’s Astrana Health ASTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.28M Buy
27,474
+18,071
+192% +$650K 0.01% 918
2026
Q1
$231K Sell
9,403
-6,164
-40% -$146K ﹤0.01% 1686
2025
Q4
$386K Sell
15,567
-19,404
-55% -$515K ﹤0.01% 1632
2025
Q3
$991K Sell
34,971
-26,250
-43% -$711K 0.01% 1169
2025
Q2
$1.52M Buy
61,221
+16,635
+37% +$468K 0.01% 942
2025
Q1
$1.38M Buy
44,586
+2,462
+6% +$82K 0.01% 995
2024
Q4
$1.33M Buy
42,124
+27,045
+179% +$1.28M 0.01% 961
2024
Q3
$874K Buy
15,079
+3,299
+28% +$162K 0.01% 891
2024
Q2
$478K Buy
+11,780
New +$467K 0.01% 818

Other funds holding ASTH

INTECH Investment Management's ASTH Position: Q2 2026 in Review

INTECH Investment Management increased its Astrana Health (ASTH) stake by 192% in Q2 2026, buying an estimated $650K and bringing the position to 27,474 shares worth $1.28M. The position accounts for 0.01% of the portfolio, ranked #918.

INTECH Investment Management first reported a position in ASTH in Q2 2024 and has held it in 9 quarters since. The position peaked at $1.52M in Q2 2025. 209 funds tracked by Wall St. Rank hold ASTH as of Q2 2026.

  • INTECH Investment Management held 27,474 shares of Astrana Health worth $1.28M as of Q2 2026.
  • INTECH Investment Management bought 18,071 Astrana Health shares in Q2 2026, an estimated $650K.
  • Astrana Health made up 0.01% of INTECH Investment Management's portfolio in Q2 2026, its #918 holding.
  • INTECH Investment Management first reported a position in Astrana Health in Q2 2024 and has held it in 9 quarters since.
  • INTECH Investment Management's Astrana Health position peaked at $1.52M in Q2 2025.
  • 209 funds tracked by Wall St. Rank held Astrana Health as of Q2 2026.

Based on INTECH Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.